Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB707

Introduced
2/6/23  
Refer
2/7/23  
Report Pass
3/2/23  
Engrossed
3/23/23  
Refer
3/29/23  
Report Pass
4/13/23  
Enrolled
4/29/24  

Caption

Public health and safety; modifying provisions related to death certificates; requiring Office of the Chief Medical Examiner to make certain disclosure. Effective date.

Impact

The implications of SB707 will significantly influence how death is reported and investigated in Oklahoma. By establishing clearer timelines for filing and formalizing communication from the medical examiner regarding investigations, the Bill seeks to reduce confusion during a sensitive time for families and ensure timely legal compliance. The enhanced deadlines for investigations also signify a commitment to address cases more swiftly, potentially leading to better resource management within the Office of the Chief Medical Examiner. Furthermore, the Bill grants immunity to medical personnel involved in certifying causes of death, aiming to balance accountability with protection for those acting in good faith.

Summary

Senate Bill 707 (SB707) has been introduced to enhance regulations regarding death certificates and the processes related to their filing and investigation. This legislation amends existing statutes by extending the timeline for filing death certificates, from three to ten calendar days post-death. Additionally, the Bill clarifies responsibilities for funeral directors, ensuring they sign and file the certificates promptly, while also providing new procedures for the Office of the Chief Medical Examiner for investigations into deaths that require official inquiry. The revisions aim to streamline the management of vital statistics concerning deceased individuals in Oklahoma, improving both the efficiency and clarity of existing protocols.

Sentiment

General sentiment surrounding SB707 has been notably positive among legislative supporters who view the changes as necessary improvements to public health and safety procedures. This Bill appears to have garnered bipartisan support, reflecting a shared recognition among lawmakers of the importance of clear and effective legislative provisions in sensitive public health matters. However, caution was raised regarding the implications of new responsibilities placed on funeral directors and the potential ethical dilemmas surrounding the immunity clause, which some fear may impede accountability in medical certification.

Contention

Notable points of contention primarily revolve around the amendments granting immunity to medical professionals for acts of omission related to death certification and investigation processes. Critics suggest that while such immunity encourages swift action in emergencies, it might also inadvertently remove necessary accountability in cases of malpractice or negligence. Moreover, some stakeholders express concern regarding the extension of timelines for death investigations, fearing it could prolong the grieving process unnecessarily for families awaiting closure. Balancing procedural efficiency with ethical considerations remains a debated topic among those affected by these legislative changes.

Companion Bills

OK SB707

Carry Over Public health and safety; modifying provisions related to death certificates; requiring Office of the Chief Medical Examiner to make certain disclosure. Effective date.

Similar Bills

LA SB286

Provides relative to the Physician's Bill of Rights. (8/1/18) (RE INCREASE SG EX See Note)

ND SB2115

Licensing and discipline of physicians and physician assistants.

CA SB920

Medical Board of California: investigations: record requests.

NJ A1236

Establishes "New Jersey Right to Try-Plus Act" permitting terminally ill patients access to certain investigational and off-label treatments.

NJ A3487

Establishes "New Jersey Right to Try-Plus Act" permitting terminally ill patients access to certain investigational and off-label treatments.

NJ S1166

Establishes "Right to Try Act" permitting terminally ill patients to access investigational drugs and treatment.

NJ A3034

Establishes "Right to Try Act" permitting terminally ill patients to access investigational drugs and treatment.

LA HB778

Provides relative to the composition of the La. State Board of Medical Examiners and investigations of physicians conducted by the board